The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suman P Shah
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suman P Shah, a promoter of Bacil Pharma Limited, sold 500 equity shares through a market sale on 24 December 2025. Before the transaction, she held 500 shares (0.00% of total voting capital), and after the sale her holding is nil. The total equity share capital of the company is 1,43,53,000 shares of Rs. 10 each, and the diluted share capital remains unchanged. The disclosure was filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011. The transaction size is negligible, representing effectively 0% of the company's share capital.
This is a routine regulatory disclosure of an extremely small share sale by an individual promoter and is unlikely to have any material effect on the stock price or shareholder sentiment.